BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25319273)

  • 1. Bisphosphonates in adjuvant setting for breast cancer: a review of the meta-analysis of bisphosphonates' effects on breast cancer recurrence presented in December 2013 at San Antonio Breast Conference.
    Costa L
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):414-9. PubMed ID: 25319273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant bisphosphonates: a new standard of care?
    Gnant M
    Curr Opin Oncol; 2012 Nov; 24(6):635-42. PubMed ID: 23042123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bisphosphonates in postmenopausal women with breast cancer.
    Gnant M
    Cancer Treat Rev; 2014 Apr; 40(3):476-84. PubMed ID: 23906846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A
    Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and breast cancer incidence and recurrence.
    Chlebowski RT; Col N
    Breast Dis; 2011; 33(2):93-101. PubMed ID: 22142660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: ready for use as adjuvant therapy of breast cancer?
    Theriault RL
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):61-6. PubMed ID: 19934757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bisphosphonates in early- and advanced-stage breast cancer: have we finally optimized care?
    Blanchette PS; Pritchard KI
    Oncology (Williston Park); 2015 Jan; 29(1):23-30, 37. PubMed ID: 25595283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Bisphosphonates and Breast Cancer Survival.
    Strobl S; Korkmaz B; Devyatko Y; Schuetz M; Exner R; Dubsky PC; Jakesz R; Gnant M
    Annu Rev Med; 2016; 67():1-10. PubMed ID: 26332000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
    Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated?
    Clemons M; Russell K; Costa L; Addison CL
    Breast Cancer Res Treat; 2012 Jul; 134(2):453-7. PubMed ID: 22562125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bisphosphonates in early breast cancer.
    Paterson AH
    Oncologist; 2006; 11 Suppl 1():13-9. PubMed ID: 16971735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
    Eisen A; Somerfield MR; Accordino MK; Blanchette PS; Clemons MJ; Dhesy-Thind S; Dillmon MS; D'Oronzo S; Fletcher GG; Frank ES; Hallmeyer S; Makhoul I; Moy B; Thawer A; Wu JY; Van Poznak CH
    J Clin Oncol; 2022 Mar; 40(7):787-800. PubMed ID: 35041467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of bisphosphonates of adjuvant therapy in breast cancer].
    Gálvez-Muñoz E; Rodríguez-Lescure Á
    Med Clin (Barc); 2010 Jun; 135(2):70-4. PubMed ID: 20022069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
    Gnant M
    Breast Dis; 2011; 33(2):71-81. PubMed ID: 22142663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer: bisphosphonate therapy for metastatic bone disease.
    Body JJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
    Strobl S; Wimmer K; Exner R; Devyatko Y; Bolliger M; Fitzal F; Gnant M
    Curr Treat Options Oncol; 2018 Mar; 19(4):18. PubMed ID: 29527635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany.
    Fick EM; Katalinic A; Waldmann A
    Cancer Res Treat; 2015 Oct; 47(4):747-56. PubMed ID: 25672584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with bone-targeted agents.
    Wilson C; Coleman RE
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):241-50. PubMed ID: 21785355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.